Title : Treatment Exposure and Discontinuation in the PALbociclib CoLlaborative Adjuvant Study of Palbociclib With Adjuvant Endocrine Therapy for Hormone Receptor-Positive\/Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer (PALLAS\/AFT-05\/ABCSG-42\/BIG-14-03) - Mayer_2022_J.Clin.Oncol__JCO2101918